Linked Life Data

19802983

Source:http://linkedlifedata.com/resource/pubmed/id/19802983

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2009-10-6
pubmed:abstractText
Clinically relevant bacterial isolates from paediatric patients were tested for in-vitro susceptibility to ceftazidime. They included 54 strains of coliform bacilli from infants with meningitis, 41 strains of coliforms which were multiply-resistant to aminoglycosides, 65 strains of Pseudomonas aeruginosa from burn unit patients, cystic fibrosis patients and other clinical specimens, and 16 miscellaneous nonfermentative bacilli. The range of MICs for coliform bacilli was from < or = 0.06 to 0.5 mg/l and the MIC90 was 0.25 mg/l. One pseudomonas isolate and two non-fermenters were resistant, but the others were susceptible with an MIC90 of 8 mg/l and a median MIC of 2 mg/l. Ceftazidime has comparable activity to moxalactam, ceftriaxone and cefotaxime against coliform bacilli and greater activity against pseudomonas strains.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0305-7453
pubmed:author
pubmed:issnType
Print
pubmed:volume
8 Suppl B
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
179-81
pubmed:meshHeading
pubmed:year
1981
pubmed:articleTitle
Activity of ceftazidime against Gram-negative bacilli from paediatric patients.
pubmed:affiliation
The University of Texas Health Science Center at Dallas, Dallas, Texas, USA.
pubmed:publicationType
Journal Article